An 84-year-old man with a medical history of chronic ischemic cardiomyopathy and diabetes mellitus underwent bursectomy of the left elbow due to purulent bursitis with Staphylococcus aureus infection. Despite initiating treatment with amoxicillin and clavulanic acid, inflammatory parameters progressed further. After switching antibiotic treatment to piperacillin/tazobactam, inflammatory parameters ameliorated, wound healing had been apparent, and the patient had been discharged. However, on the twelfth postoperative day, the patient was readmitted with a palpable, purpuric rash of all extremities with livid-colored, partly bullous and partly necrotic skin lesions (Fig. 1). Parainfectious leucocytoclastic vasculitis was suspected and prednisolone 50 mg once daily was initiated, however, wound healing, skin lesions and patient's clinical condition deteriorated with additional acute heart failure, melena and epistaxis during the next six days. Furthermore, skin biopsy could not confirm leucocytoclastic vasculitis. Laboratory testing revealed mild hypofibrinogenemia, thrombocytopenia, antithrombin III deficit, elevated D-dimer and C-reactive protein of 24 mg/l, while antinuclear, antineutrophilic cytoplasmatic and C1q antibodies were negative. Consecutively, the patient revealed increasing signs of acute heart failure, so a scheduled skin grafting due to postoperative wound healing disorder was waived. Despite maximum therapy escalation, patient's condition further deteriorated, and he finally died due to cardiac arrest. A repeated wound swab of the elbow revealed Stenotrophomonas maltophilia, sensitive to trimethoprim/sulfonamide but no MRSA was found. At the time the patient died, this information was not available due to delayed swab results. Therefore, no appropriate antibiotic treatment could be initiated, and no blood cultures were done. Due to laboratory and clinical changes, incipient disseminated intravascular coagulation was suggested.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to The American Journal of the Medical Sciences
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.Clin Microbiol Rev. 2012; 25: 2-41
- Stenotrophomonas maltophilia infections: clinical characteristics in a military trauma population.Diagn Microbiol Infect Dis. 2020; 96114953
Published online: February 03, 2022
Accepted: January 26, 2022
Received: September 18, 2020
© 2022 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.